Aurobindo Pharma News: Read Latest News & Live Updates on Aurobindo Pharma, Photos, Videos at CNBCTV18.com

homeAurobindo Pharma News

Aurobindo Pharma NEWS

All

market | Apr 15, 2024 12:47 PM IST
Aurobindo Pharma shares drop amid 3 USFDA observations to company's Eugia Sterile unit
business | Apr 5, 2024 6:45 PM IST
Aurobindo Pharma arm gets 3 observations from US FDA after Andhra unit inspection
business | Mar 19, 2024 7:31 PM IST
Aurobindo Pharma gets US FDA final approval for nasal spray to treat allergies
market | Feb 16, 2024 2:57 PM IST
Aurobindo Pharma shares jump over 3% as USFDA completes inspection at Telangana unit with zero observations
market | Feb 14, 2024 3:26 PM IST
Aurobindo Pharma under USFDA scrutiny: What investors need to know
market | Feb 12, 2024 4:39 PM IST
Aurobindo Pharma gets USFDA approval for muscular dystrophy tablets
market | Feb 5, 2024 8:11 AM IST
Aurobindo Pharma unit to sell business assets to Empower for $52 million plus lease payments
market | Feb 1, 2024 10:46 AM IST
Aurobindo Pharma confirms CNBC-TV18 newsbreak, says inspection ongoing at Unit 4
market | Jan 17, 2024 2:25 PM IST
Aurobindo Pharma subsidiary receives CDSCO nod for breast cancer treatment drug
business | Jan 10, 2024 5:10 PM IST
Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around ₹4,500 crore
business | Jan 8, 2024 8:59 PM IST
Aurobindo Pharma's Telangana unit classified as 'Voluntary Action Indicated' after USFDA scan — what it means
market | Jan 2, 2024 4:27 PM IST
Elara Securities outlines key trends and top picks in the pharma sector
market | Dec 20, 2023 1:12 PM IST
Aurobindo Pharma arm's Tirupati facility gets VAI classification from USFDA, stock hits record high
market | Nov 30, 2023 1:13 PM IST
Aurobindo Pharma shares gain after its arm gets USFDA nod for asthma treatment drug for children
healthcare | Nov 28, 2023 12:58 PM IST
Cipla share price: The market is afraid about risks that don't exist, says Bernstein

Aurobindo Pharma NEWS

Aurobindo Pharma shares drop amid 3 USFDA observations to company's Eugia Sterile unit

Aurobindo Pharma arm gets 3 observations from US FDA after Andhra unit inspection

Aurobindo Pharma gets US FDA final approval for nasal spray to treat allergies

Aurobindo Pharma shares jump over 3% as USFDA completes inspection at Telangana unit with zero observations

Aurobindo Pharma under USFDA scrutiny: What investors need to know

Aurobindo Pharma gets USFDA approval for muscular dystrophy tablets

Aurobindo Pharma unit to sell business assets to Empower for $52 million plus lease payments

Aurobindo Pharma confirms CNBC-TV18 newsbreak, says inspection ongoing at Unit 4

Aurobindo Pharma subsidiary receives CDSCO nod for breast cancer treatment drug

Aurobindo Pharma now weighs mega IPO of Eugia Pharma Specialities to raise around ₹4,500 crore

Aurobindo Pharma's Telangana unit classified as 'Voluntary Action Indicated' after USFDA scan — what it means

Elara Securities outlines key trends and top picks in the pharma sector

Aurobindo Pharma arm's Tirupati facility gets VAI classification from USFDA, stock hits record high

Aurobindo Pharma shares gain after its arm gets USFDA nod for asthma treatment drug for children

Cipla share price: The market is afraid about risks that don't exist, says Bernstein